PYZTELUS Trademark

Trademark Overview


On Tuesday, February 28, 2023, a trademark application was filed for PYZTELUS with the United States Patent and Trademark Office. The USPTO has given the PYZTELUS trademark a serial number of 79367047. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, February 15, 2024. This trademark is owned by SAMSUNG BIOEPIS CO., LTD.. The PYZTELUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparation...
pyztelus

General Information


Serial Number79367047
Word MarkPYZTELUS
Filing DateTuesday, February 28, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, February 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; anti-inflammatory preparations; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for skin treatment; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease; dietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, February 15, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, February 15, 2024ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, February 15, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, August 22, 2023REFUSAL PROCESSED BY IB
Thursday, August 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 3, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 27, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Thursday, June 22, 2023ASSIGNED TO EXAMINER
Tuesday, April 18, 2023APPLICATION FILING RECEIPT MAILED
Wednesday, April 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 10, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, April 7, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB